Here is the part that does not quite add up.
Salesforce just posted the fastest-growing product in its entire history. Agentforce, the company’s autonomous AI agent platform, crossed $1.2 billion in annual recurring revenue in the most recent quarter, up 205% year-over-year. The company has closed 29,000 Agentforce deals since the product launched. More than 60% of those bookings came from existing customers expanding their spend.
And the stock is sitting near a 52-week low.
The gap between those two things is where the real investment debate lives right now.
Wall Street has been hammering the entire enterprise software sector on fears that AI tools from Anthropic and OpenAI will let companies build their own replacements for legacy SaaS applications. The concern is not irrational. But what gets lost in the panic is that Salesforce is not a passive victim of AI disruption. It is actively monetizing AI as its fastest-growing business line. CEO Marc Benioff has said that Anthropic runs its operation on Salesforce and Slack.
That is the kind of detail that tends to get buried when the broader sector is in freefall.
Slight tangent, but worth noting: Salesforce has been active on M&A and investments. The most recent is a $3.6 billion deal for Fin, a customer service AI platform that says it has 30,000 customers. Salesforce has also announced a $2 billion AI investment in France through 2030. That is not a company in retreat. It is a company reshaping its business model around AI infrastructure at an aggressive pace.
The financial picture supports a second look. In fiscal year 2026, revenue came in at $41.5 billion, up about 10% year-over-year. Non-GAAP EPS of $3.88 in the most recent quarter grew 50% year-over-year. The company’s combined Agentforce and Data 360 ARR has already reached nearly $3.4 billion. Operating margins are expanding, and the company commenced a $25 billion accelerated share repurchase as part of a broader $50 billion authorization.
Yet the stock, currently trading near $170, sits at roughly 11 times forward earnings. That is a historically compressed multiple for a business with those growth metrics. The 52-week range runs from $146.32 to $274.00, and the consensus analyst price target sits near $245, implying roughly 44% upside from current levels.
The bear case is real and worth taking seriously. KeyBanc downgraded CRM in early July, citing customer conversations that suggested Agentforce adoption may take longer than expected to convert into material revenue. Some smaller companies are reportedly using Claude to reduce their Salesforce footprint. Full-year revenue guidance landed slightly below consensus when the company reported in late May, which added to the pressure.
What is interesting is that the bull case and bear case are essentially arguing about the same thing: timing. Bulls say the Agentforce monetization cycle is just getting started. Bears say it will take longer than expected. Nobody serious is arguing that AI is killing Salesforce’s revenue base overnight.
The next real data point is the Q2 fiscal 2027 earnings report, expected in late August or early September. That will provide the first clean read on whether the organic revenue reacceleration the company is guiding for in the second half of fiscal 2027 is materializing on schedule. Until then, the stock is sitting at one of the most interesting valuation gaps in enterprise tech.
Whether the AI disruption fear is justified or overblown, the business continues to generate significant free cash flow, expand margins, and close thousands of new Agentforce contracts each quarter. The market has priced in the worst case. The fundamentals have not confirmed it.
That is the kind of tension that tends to resolve one way or the other, usually with speed.
Disclaimer: This editorial is for informational purposes only and does not constitute investment advice. All figures are sourced from publicly available company filings and analyst reports. Past performance is not indicative of future results. Investors should conduct their own due diligence before making any investment decisions.
